Evidence map›Paper›PMID 20871215›Full record

ArticleThe American journal of surgical pathology2010

Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas.

Nobuyuki Ohike, Ipek Coban, Grace E Kim, Olca Basturk, Takuma Tajiri, Alyssa Krasinskas, Sudeshna Bandyopadhyay, Toshio Morohoshi, Yuki Shimada, David A Kooby and 4 more

Erratum issuedOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in The American journal of surgical pathology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Tumor Budding Assessment with Cytokeratin and Its Significance in Laryngeal Squamous Cell Carcinomas.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2022
    Article
  7. Article
  8. Article
  9. Analysis of Endoscopy Findings to Identify Early Gastric Cancers with Tumor Budding: A Retrospective Study.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2021
    Article
  10. Article
  11. Tumour budding in solid cancers.Nature reviews. Clinical oncology · 2021
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Primary small bowel adenomas and adenocarcinomas-recent advances.Virchows Archiv : an international journal of pathology · 2018
    Review
4 · The record

Corrections and comments

  • Erratum issued
    Volkan Adsay, Nazmi [corrected to Adsay, N. Volkan]
5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Nobuyuki OhikeDepartments of Pathology, Emory University Hospital, Atlanta, GA, USA.
Ipek Coban
Grace E Kim
Olca Basturk
Takuma Tajiri
Alyssa Krasinskas
Sudeshna Bandyopadhyay
Toshio Morohoshi
Yuki Shimada
David A Kooby
Charles A Staley
Michael Goodman
N Volkan Adsay
Nazmi Volkan Adsay
University of California, San Francisco · USMemorial Sloan Kettering Cancer Center · USShowa University · JPShowa University Fujigaoka Hospital · JPThe Barbara Ann Karmanos Cancer Institute · USUniversity of Pittsburgh · US

Funding

Tumor Antigens for Individual Signatures and TherapyP50CA062924 · NCI · JOHNS HOPKINS UNIVERSITY · PI KERN, SCOTT E · 1993 to 2022
$54.6M
SPORE in Pancreatic CancerP20CA101936 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ABBRUZZESE, JAMES L. · 2003 to 2009
$5.4M
GENETIC EPIDEMIOLOGY OF PANCREAS CANCERR03CA088273 · NCI · JOHNS HOPKINS UNIVERSITY · PI HRUBAN, RALPH H · 2000 to 2000
$82k
NCI NIH HHS CA101936NCI NIH HHS P20 CA101936NCI NIH HHS P50 CA062924NCI NIH HHS R03 CA088273
6 · The paper itself

Abstract

Prognostication of invasive ampullary adenocarcinomas (AACs) and their stratification into appropriate management categories have been highly challenging owing to a lack of well-established predictive parameters. In colorectal cancers, recent studies have shown that tumor budding confers a worse prognosis and correlates significantly with nodal metastasis and recurrence; however, this has not been evaluated in AAC.To investigate the prevalence, significance, and clinical correlations of tumor budding in AAC, 244 surgically resected, stringently defined, invasive AAC were analyzed for tumor budding---defined as the presence of more than or equal to 5 isolated single cancer cells or clusters composed of fewer than 5 cancer cells per field measuring 0.785 mm using a 20× objective lens in the stroma of the invasive front. The extent of the budding was then further classified as "high" if there were greater than or equal to 3 budding foci and as "low" if there were <3 budding foci or no budding focus.One hundred ninety-four AACs (80%) were found to be high-budding and 50 (20%) were low-budding. When the clinicopathologic features and survival of the 2 groups were compared, the AACs with high-budding had larger invasion size (19 mm vs. 13 mm; P<0.001), an unrecognizable/absent preinvasive component (57% vs. 82%; P<0.005), infiltrative growth (51% vs. 2%; P<0.001), nonintestinal-type histology (72% vs. 46%; P<0.001), worse differentiation (58% vs. 10%; P<0.001), more lymphatic (74% vs. 10%; P<0.001), and perineural invasion (28% vs. 2%; P<0.001); more lymph node metastasis (44% vs. 17%; P<0.001), higher T-stage (T3 and T4) (42% vs. 10%; P<0.001), and more aggressive behavior (mean survival: 50 mo vs. 32 mo; 3-year and 5-year survival rates: 93% vs. 41% and 68% vs. 24%, respectively; P<0.001). Furthermore, using a multivariable Cox regression model, tumor budding was found to be an independent predictor of survival (P=0.01), which impacts prognosis (hazard ratio: 2.6) even more than T-stage and lymph node metastasis (hazard ratio: 1.9 and 1.8, respectively).In conclusion, tumor budding is frequently encountered in AAC. High-budding is a strong independent predictor of overall survival, with a prognostic correlation stronger than the 2 established parameters: T-stage and lymph node metastasis. Therefore, budding should be incorporated into surgical pathology reports for AAC.

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overAmpulla of VaterCommon Bile Duct NeoplasmsFemaleHumansLymphatic MetastasisMaleMiddle AgedNeoplasm InvasivenessPrecancerous ConditionsPrognosisSurvival RateUnited States

Identifiers

PMID20871215
PMCPMC3163902
OpenAlexW1975098212

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.